Background-Survivors of nonfatal coronary heart disease (CHD) can reduce their risk of further events by various preventive interventions. The impact of such measures as delivered over 11 years, on population rates of subsequent major CHD events, has not been extensively studied. This study determined population trends in the prevalence of clinically manifest CHD and the proportion of major CHD events that occur in this population.
P eople with established coronary heart disease (CHD) are at greatly increased risk of further vascular events compared with CHD-free individuals of similar age and sex. 1, 2 Randomized controlled trials have clearly established that this excess risk can be reduced by a wide range of interventions, including coronary revascularization, medical treatment, and rehabilitation, referred to collectively as "secondary prevention." 3 However, the population impact of secondary prevention as delivered from 1995 to 2005 on rates of major CHD events is unknown and requires knowledge of both the prevalence of established CHD and the fraction of such events that occur in this population. We have addressed this by using data from the Western Australian Health Data Linkage System that has linked routinely collected statewide health administrative data, includ-ing hospital morbidity data and death records, dating from 1980 into cumulative personal records. 4 The specific objectives of our study were to describe (1) trends in the prevalence of previous hospital admission for CHD in surviving men and women ages 35 to 84 years between 1995 and 2005; (2) annual counts and rates of major CHD events (nonfatal myocardial infarction (MI) and CHD death) by sex and history of established CHD; and (3) the relative risk of major CHD events in those with established CHD compared with the CHD-free population.
Methods

Setting
Western Australia has the largest area of the 6 states of Australia, and a population of 2.2 million in 2009. Since 1995, the adult population ages 35 to 84 years has increased by about a third from 611 869 to 786 727 in 2005. All major medical services for the management of CHD are concentrated in the capital city, Perth, which contains approximately 75% of the state's total population (currently 1.6 million) and is situated 1000 miles from the nearest major city. Provision of medical treatment to Perth residents outside the state is rare, and migration in those age 50ϩ years is estimated at Ͻ1%. 5 Facilities for the tertiary management of CHD are located in eight major public and private hospitals in Perth.
WHAT IS KNOWN
• Persons with established coronary heart disease (CHD) are at much higher risk of recurrent events or death than the general population. • Survivors of CHD events are a major target of secondary prevention.
WHAT THE STUDY ADDS
• Nearly half of all such CHD events occur in the 6% of the general population with established disease, highlighting the greater need for effective secondary prevention. • The proportion of nonfatal and fatal CHD events occurring in people with established disease has remained stable from 1995 to 2005.
Subjects
The study includes all residents of the Perth Statistical Division ages 35 to 84 years.
Data Sources
Linked data were extracted from both the State Hospital Morbidity Data System and the Death Registry for the period January 1, 1980, to December 31, 2005, permitting a 15-year lead-in interval for all major CHD events occurring in the study period. The morbidity data set covers all public and private hospital admissions in Western Australia (up to 21 discharge diagnoses). The Western Australian Register of Deaths, which includes place and certified cause of death (including multiple causes since 1997) similarly, covers all deaths in the State and nationally from 2002. Diagnoses of MI using administrative morbidity data, as well as the causes of death from CHD in the Death Register, have been validated previously. 6, 7 
Identification and Estimation of Populations With and Without Established CHD
Hospital admissions and deaths from CHD were identified using the International Classification of Diseases (ICD) codes incorporating ICD-9 revision, ICD-9 clinical modification, and ICD-10 Australian Modification. 8 Events were identified using codes 410 to 414 (ICD-9 versions) and I20-I25 (ICD-10). Hospitalizations for MI were identified using codes 410 (ICD-9 versions), I21 and I22 (ICD-10).
The population with established CHD for each year from 1995 to 2005 was identified as those who were alive at June 30 who had a hospital admission for CHD in any diagnosis field in the preceding 15 years. The CHD-free population was the total population counts at June 30 each calendar year less the population with established CHD for that year.
Major CHD events for each year from 1995 to 2005 were defined as death from CHD or hospital admissions for MI as the principal discharge diagnosis. Hospitalizations for MI were categorized as fatal or nonfatal (alive at 28 days from the date of admission). Fatal cases included hospital admissions with a principal discharge diag-nosis other than MI with a coded cause of death of CHD. Other CHD deaths were those that occurred out of hospital. Major CHD events occurring in the population with established CHD for a given calendar year were considered recurrent. Rehospitalization and transfers between hospitals within 28 days of a qualifying event were counted once only.
The study was approved by the Human Research Ethics Committee of the University of Western Australia and the Confidentiality of Health Information Committee of the Western Australian Department of Health.
Statistical Methods
Men and women were analyzed separately. Crude age-specific prevalence was calculated as the established CHD count divided by the Perth population estimate and the age-standardized prevalence obtained for each year by the direct method using the total population of Perth in 2001 as the standard. 9 Nonfatal MI, CHD deaths, and total CHD events were tabulated by age, history of CHD, and calendar year to determine the proportion of events within the populations with and without established CHD. Trends by calendar year in the rates of each type of event occurring in the populations with and without established CHD were examined using Poisson regression (Proc Genmod in SAS, 10 ) to adjust for age.
Age-specific rates for first and recurrent events were calculated for each year using the estimated populations for CHD-free and with established CHD, respectively. Age-standardized event rates for each year were calculated by the direct method using weights derived from the total population and those with established CHD, respectively.
Results
Study Population and Major CHD Events
A general description of the study population and counts of major nonfatal and fatal CHD events by history of disease are shown in the Table. The annual CHD-free populations for men and women ages 35 to 84 years averaged approximately 314 000 and 324 000, respectively. The equivalent average populations with previous admission for CHD was 28 373 (8.8%) in men and 14 966 (4.0%) in women. During the study, there were 28 941 major CHD events, of which a third were in women. The percentage of total CHD events occurring in the population with established CHD was approximately 43% in both men and women, for CHD death 55% and 51%, and for nonfatal MI 35% and 36%, respectively. In those with established CHD 30% had more than 1 recurrent event. Further, 51% of events in those with prior CHD and 61% of all such events occurred in those younger than 75 years.
Annual average crude rates for each major CHD category in men and women with and without established CHD are also shown in the Table. Rates of total CHD events in the population with established CHD are seen to be many times higher than in the CHD-free population in both men and women, but these gross differences are difficult to interpret without adjustment for age and calendar year. Using Poisson regression and adjusting for age and calendar year, the relative risk for total CHD events in those with established CHD compared with CHD-free men was 2.4 (95% confidence interval [CI], 1.9 to 2.8) and in women 2.9 (95% CI, 2.3 to 3.5).
Trends in Prevalence of CHD
Age-standardized prevalence rose marginally to peak in the late 1990s at approximately 9.1% of men and 4.2% of women, thereafter gradually declining to below 1995 levels in women and more so in men ( Figure 1A ). Age-specific prevalence of CHD in men increased rapidly from Ͻ1% in the 35 to 39 year age group to 42% in 80-to 84-year-olds, compared with Ͻ1% to 38% in 2005 ( Figure 1B) . The comparative prevalence for women of the same age strata were Ͻ1% to 22% in both years. Figure 2 shows that there were no obvious trends in the proportions of fatal and nonfatal CHD events within the population with established CHD for either men or women. Figure 3 shows age-standardized trends in rates of fatal CHD, nonfatal CHD, and total events by disease history and sex. Rates of total CHD events for both populations with and without CHD fell 3.5% per year (95% CI, 2.9% to 4.1%) in women and 3.3% per year (95% CI, 2.9% to 3.7%) in men. Corresponding fatal major CHD rates fell 7.0% per year in both men (95% CI, 6.3%, 7.6%) and women (95% CI, 6.1%, 7.8%) from 1995 to 2005. In contrast, there were only modest changes in rates of nonfatal MI in men and women, which were stable or increasing slightly, with the trend in women not being statistically significant (PϾ0.05). Similar trends in major CHD events were seen in men and women with and without established CHD. The interaction term for calendar year by history of CHD for total CHD event rates was not statistically significant (Pϭ0.65), suggesting the relative risk of a major CHD event for those with and without a history of CHD did not change over the study period. Figure 4 shows rates of nonfatal MI and fatal and total CHD events in established CHD and CHD-free men and women by age. Rates were substantially higher in all age groups for established CHD compared with CHD-free men and women. Although rates tended to increase with age, this was much less so in the population with established CHD in which rates were relatively unchanged under 65 years but then gradually increasing. As a consequence, the relative risk of both total and fatal CHD events in the population with established CHD compared with CHD-free population declined with age in both sexes, with women having higher relative risk than men ( Figure 5 ).
Trends in Major CHD Events According to Previous Diagnosis
Trends in Age-Specific Rates and Relative Risk of a Major CHD Event
Discussion
From 1995 to 2005, some 8.8% of men and 4.0% of women ages 35 to 84 years with established CHD accounted for more then 50% of CHD deaths and approximately 40% of nonfatal MI occurring in the total population. These broad estimates suggest that a 10% reduction in the average risk of major CHD events in the populations with established CHD would result in a reduction in total population CHD deaths of approximately 5%. Our findings underscore the urgent need for measures to maximize the impact of secondary prevention and thereby bridge the guideline treatment gap (eg, all patients treated with aspirin, statins, and rehabilitation).
Other population studies in people with established CHD have found similar age-specific and sex differences and either stable or no clear trends in disease prevalence, with higher estimates in health administrative data sets compared with self-reported data. [11] [12] [13] [14] [15] [16] [17] Against a declining population with established CHD are recent reports of a flattening of agespecific CHD mortality rates among 35-to 44-year-olds and 45-to 54-year-olds in the United States and United Kingdom, in which increasing rates of overweight and diabetes have been implicated. 11, 18 During the study period, age-adjusted mortality rates from CHD fell sharply but at approximately the same rate in the populations with and without CHD, whereas rates of nonfatal MI remained virtually unchanged in both. The decline in mortality rates is consistent with the long-term decline in age-adjusted CHD mortality that commenced in Australia in the late 1960s and has continued since. 12, 19 The leveling out of rates for MI in the total population during the study period, demonstrated here in both populations with and without established CHD, is likely to be an artifact caused by the rapid and widespread uptake of troponin assays for the diagnosis of MI since 1996. 19 This is supported by unpublished observations that rates of admission for unstable angina and all other CHD diagnoses in Perth have fallen consistently since 1993, suggesting transference of cases that would have previously been diagnosed as angina to MI. The decrease in admissions for all CHD thus appears to have balanced improved survival in the population with established CHD during the study period, so that prevalence remained relatively stable. Other studies report favorable changes in the prognosis of patients with acute MI. 1, 14, 18 Interestingly, the Worcester Heart Attack Study 14 found that patients who died during 1-year follow-up were consistently less likely to have been treated with effective drugs or coronary revascularization during their acute hospitalization. Paradoxically, in clinical practice, those at higher risk, including the elderly, may be less likely to receive evidencebased therapies. 
Possible Reasons for the Decline in Mortality Rates in the Population With Established CHD
The parallel fall in mortality rates in the populations with and without established CHD suggests that the same lifestyle changes that are assumed to have led to declining mortality in the CHD-free population may also have contributed to the falling rates in the population with established CHD. However, in view of the marked differences in overall risk of CHD death and differences in patterns of risk by age and sex between the 2 populations, it is unlikely that this is the only or principal explanation. For example, the customary difference in death rates from CHD in women and men was not found in the population with established CHD, whereas the anticipated increase in rates with advancing age was much less pronounced in the population with established CHD than in the CHD-free group. Alternative explanations for the fall in death rates in the population with established CHD include declining severity of disease, increased use of coronary revascularization, and proven medical therapies (eg, lipidlowering drugs and angiotensin-converting enzyme inhibitors). 20 -22 
Relative Risk of Major CHD Events in the Population With Established CHD
In addition to the absolute numbers and proportions of major CHD events in the populations with and without established CHD, we estimated the relative risk of further events in those with established CHD compared with CHD-free population.
After adjustment for age and calendar year, the relative risk for CHD death was 4.1 (95% CI, 3.9 to 4.3) in men and 5.6 (95% CI, 5.3 to 6.0) in women, and, for nonfatal MI, 3.1 (95% CI, 3.0 to 3.2) and 4.5 (95% CI, 4.2 to 4.8), respectively. Comparable estimates in the United States without adjustment for age are 1.5-to 15-fold greater. 23 As large as these overall relative risks are, they mask even larger relative risks at younger ages because of the much flatter increase in rates of recurrent events with age in the population with established CHD compared with the exponential increase with age in the CHD-free population. Although the immediate impact on total population events of the very high relative risk in the prevalent age groups Ͻ55 years is relatively small (for example, 16 events per 100 000 in men and 3 per 100 000 in women), the longer-term impact on (quality) years of life lost will obviously be much greater.
Study Limitations
Our estimates of the prevalence of clinically manifest CHD and the fractions of major CHD events occurring in this subpopulation based only on previous hospital admissions are almost certainly conservative as they exclude not only persons with CHD who have never been hospitalized but also persons who may have had such admissions before entering Western Australia. This may be balanced partially by persons who have left Western Australia, including those who have had major CHD events elsewhere, but net population migration, based on official population census estimates, has for many years been strongly positive. A previous follow-up study of persons who had coronary artery bypass graft surgery that matched the cohort to the National Death Index identified no deaths outside Western Australia. 24 The prevalence of CHD may have also been overestimated by failures in the linkage of hospital records to death records, but the audit processes of the WADLS suggest that such failures are rare (0.11%). 4 Our methods will not have captured MIs that have been either undiagnosed or diagnosed and treated in primary care. However, we have previously shown that a negligible proportion of patients (Ͻ1%) with recognized nonfatal MI in Perth are treated solely at home, 25 and there is no evidence to suggest that this has increased since that time. On balance, we believe that our estimates of both prevalence and recurrent events have been conservative.
Major CHD event records are subject to misclassification and miscoding in administrative data sets. However, we have previously shown that trends of nonfatal MI based on principal discharge diagnoses in the Hospital Morbidity Data System are valid. 6, 7 Further, near complete follow-up (estimated at 99%) was ensured through the well-established data linkage procedures. Counts of recurrent events may have been overestimated by our arbitrary use of 28 days to define episodes of nonfatal MI. Although this excludes readmissions within 28 days, a longer event period of, for example, 90 days, would exclude further readmissions or deaths that might reasonably be considered as part of the initial event and not necessarily amendable to preventive interventions.
Conclusion
From 1995 to 2005, just under half of all CHD death or nonfatal MI occurred in approximately 6% of the population with a prior hospitalization for CHD. This occurred despite long-term declines in CHD deaths, including in the population with established CHD. Given our growing and aging population, these findings highlight the imperative to implement improved systems of care that support effective secondary prevention.
